AGT and cardiac hypertrophy: Mice lacking Gpx1 display increased cardiac hypertrophy in response to prolonged angiotensin II infusion and display increased infarct sizes following IRI8,9, suggesting that the loss of Gpx1 potentiates cardiac disease.